Skip to main content

Table 2 Mean signal intensities of various proteins and peptides comparing endometrium of women with a normal pelvis versus endometriosis (CM10 and IMAC)

From: TRIzol treatment of secretory phase endometrium allows combined proteomic and mRNA microarray analysis of the same sample in women with and without endometriosis

CM10    
CHCA     
M/z pvalue Mean Disease Mean Control Up/down
14653,82 0,034 0,795 1,468 down
16851,18 0,020 0,378 0,660 down
SPAhigh     
8776,32 0,020 0,854 0,310 up
8898,40 0,045 4,530 1,935 up
10115,90 0,034 7,442 3,545 up
12186,64 0,026 0,300 0,132 up
12379,95 0,011 2,028 0,420 up
12683,46 0,026 0,988 0,444 up
13464,70 0,045 0,361 0,198 up
14479,03 0,011 0,282 0,116 up
17258,59 0,034 0,370 0,168 up
SPAlow     
7662,79 0,045 0,247 0,362 down
8949,82 0,026 1,310 0,720 up
9177,29 0,020 0,391 1,381 down
9941,98 0,026 2,221 1,234 up
10084,76 0,045 1,807 1,096 up
11477,23 0,034 0,087 0,167 down
12323,14 0,011 0,652 0,215 up
12623,72 0,045 0,375 0,219 up
IMAC    
CHCA  
M/z pvalue Mean Disease Mean Control Up/down
6299,93 0,011 0,319 0,470 down
9213,51 0,008 0,607 1,578 down
9266,22 0,011 0,933 1,440 down
9766,19 0,034 0,699 0,360 up
11163,87 0,020 0,527 0,245 up
11322,71 0,015 1,017 0,294 up
15446,04 0,004 0,586 0,108 up
SPAhigh     
9532,42 0,026 3,217 13,993 down
9767,55 0,045 2,180 4,258 down
SPAlow     
7832,06 0,020 0,205 0,369 down
8228,62 0,004 0,389 0,198 up
9190,05 0,015 0,420 1,406 down
9262,94 0,034 0,900 0,502 up